about
Elimination of Mother-To-Child Transmission of HIV Infection: The Drug Resource Enhancement against AIDS and Malnutrition ModelMaternal antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Malawi: maternal and infant outcomes two years after deliveryImmunologic response to highly active antiretroviral therapy and mortality reduction in a cohort of human immunodeficiency virus-positive persons in Mozambique.Viral sequence analysis of HIV-positive women and their infected children: insight on the timing of infection and on the transmission network.Evaluation of the nutritional status of infants from mothers tested positive to HIV/AIDS in the health district of Dschang, Cameroon.Nutritional rehabilitation of HIV-exposed infants in Malawi: results from the drug resources enhancement against AIDS and malnutrition programExtended antenatal use of triple antiretroviral therapy for prevention of mother-to-child transmission of HIV-1 correlates with favorable pregnancy outcomes.Incidence and predictors of death, retention, and switch to second-line regimens in antiretroviral- treated patients in sub-Saharan African Sites with comprehensive monitoring availability.Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.Predictors of adverse outcomes in HIV-1-infected children receiving combination antiretroviral treatment: results from a DREAM cohort in sub-Saharan Africa.Increased infant human immunodeficiency virus-type one free survival at one year of age in sub-saharan Africa with maternal use of highly active antiretroviral therapy during breast-feeding.A pharmacogenetics study in Mozambican patients treated with nevirapine: full resequencing of TRAF3IP2 gene shows a novel association with SJS/TEN susceptibilityHepatitis B virus mother-to-child transmission among HIV-infected women receiving lamivudine-containing antiretroviral regimens during pregnancy and breastfeeding.Extended antenatal antiretroviral use correlates with improved infant outcomes throughout the first year of life.Weight changes during and after 6 months of breastfeeding in HIV-infected mothers receiving antiretroviral therapy in Malawi.Hepatitis in Albanian children: molecular analysis of hepatitis A virus isolates.Predicting trends in HIV-1 sexual transmission in sub-Saharan Africa through the Drug Resource Enhancement Against AIDS and Malnutrition model: antiretrovirals for 5 reduction of population infectivity, incidence and prevalence at the district levelNucleotide correlation between HAV isolates from human patients and environmental samples.Laboratory confirmation of clinically diagnosed malaria in a cohort of HIV-infected mothers and their children in Malawi.The DREAM model's effectiveness in health promotion of AIDS patients in Africa.Correction: Reduction of Maternal Mortality with Highly Active Antiretroviral Therapy in a Large Cohort of HIV-Infected Pregnant Women in Malawi and Mozambique
P50
Q26778483-1BCAF669-5F38-4E23-9D05-23A1A1FC6F1EQ28534751-D43724AA-1DF0-4B1E-B997-F20D30321EC3Q34240160-AEB39A35-A9A9-4D24-9CAD-CA1E3B9D4274Q34266269-A7CCC223-F403-4881-BA0C-8E403EC3BC67Q34507701-02333F9A-F377-406C-A40A-53B9BCCF1028Q35860439-F74881DE-90CC-4C9B-AC85-B3F830C69A85Q37889592-4A1906E8-4E77-43C8-8F7E-EEABFBFBF967Q38452483-2DD8D27A-82FF-4AA3-98D2-34795178C9F8Q38966133-1088884B-D890-462F-939C-14D6E3266F01Q39213753-9C1A9DA8-6990-4134-81FC-D34A8156560DQ39213760-D0B84EFA-3C4C-469C-9107-B9C4E5355A74Q39555733-A44188E1-C7A3-4A9A-BC7B-67D387A2EF00Q41760045-F099CF7F-3D5E-4A60-B066-334FE31DC74EQ42872394-48E6C211-10F7-4272-9D0D-7927C1FBF133Q43049052-CE14391C-8896-4275-A121-7AEF9BD6FF7EQ44775285-2C76BE61-091D-4F2F-8D08-A667AA356A7AQ44799271-10929DF7-9D35-49AA-ACD1-08A2E5E3BC08Q45150537-DD60B839-A6EB-4BAF-BA0D-F49825E62DFAQ46142443-6BFEE61C-1913-4DAB-878C-3230EBC19D20Q53117150-82BD154E-6955-4CB7-986E-0D4B18A08D36Q57951537-3BCA2798-EEB8-478C-917D-8CC97EDD6AC1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ersilia Buonomo
@ast
Ersilia Buonomo
@en
Ersilia Buonomo
@es
Ersilia Buonomo
@nl
type
label
Ersilia Buonomo
@ast
Ersilia Buonomo
@en
Ersilia Buonomo
@es
Ersilia Buonomo
@nl
prefLabel
Ersilia Buonomo
@ast
Ersilia Buonomo
@en
Ersilia Buonomo
@es
Ersilia Buonomo
@nl
P106
P1153
7004025148
P31
P496
0000-0002-3924-9917